BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 1905975)

  • 1. Therapy of spontaneous lung metastasis of murine renal adenocarcinoma by systemic administration of liposomes containing the macrophage activator CGP 31362.
    Dinney CP; Bucana CD; Utsugi T; Fidler IJ; von Eschenbach AC; Killion JJ
    Cancer Res; 1991 Jul; 51(14):3741-7. PubMed ID: 1905975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy of murine renal adenocarcinoma by systemic administration of liposomes containing the synthetic macrophage activator CGP 31362 or CGP 19835A in combination with interleukin 2 or gamma-interferon.
    Dinney CP; Utsugi T; Fidler IJ; von Eschenbach AC; Killion JJ
    Cancer Res; 1992 Mar; 52(5):1155-61. PubMed ID: 1531322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ activation of mouse lung macrophages by coadministration of liposomes containing the lipopeptide CGP 31362 and interleukin 2 involves interaction with T lymphocytes and natural killer cells.
    Utsugi T; Dinney CP; Killion JJ; Brown D; Fidler IJ
    Lymphokine Cytokine Res; 1991 Dec; 10(6):487-93. PubMed ID: 1804312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ activation of mouse macrophages and therapy of spontaneous renal cell cancer metastasis by liposomes containing the lipopeptide CGP 31362.
    Utsugi T; Dinney CP; Killion JJ; Fidler IJ
    Cancer Immunol Immunother; 1991; 33(6):375-81. PubMed ID: 1878891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct correlation between expression of endogenous inducible nitric oxide synthase and regression of M5076 reticulum cell sarcoma hepatic metastases in mice treated with liposomes containing lipopeptide CGP 31362.
    Xie K; Huang S; Dong Z; Gutman M; Fidler IJ
    Cancer Res; 1995 Jul; 55(14):3123-31. PubMed ID: 7541713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
    Hillman GG; Younes E; Visscher D; Hamzavi F; Kim S; Lam JS; Montecillo EJ; Ali E; Pontes JE; Puri RK; Haas GP
    Clin Cancer Res; 1997 Oct; 3(10):1799-806. PubMed ID: 9815566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators.
    Fidler IJ; Barnes Z; Fogler WE; Kirsh R; Bugelski P; Poste G
    Cancer Res; 1982 Feb; 42(2):496-501. PubMed ID: 7055801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages.
    Fidler IJ; Raz A; Fogler WE; Kirsh R; Bugelski P; Poste G
    Cancer Res; 1980 Dec; 40(12):4460-6. PubMed ID: 7002293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergism between lymphokines and muramyl dipeptide encapsulated in liposomes: in situ activation of macrophages and therapy of spontaneous cancer metastases.
    Fidler IJ; Schroit AJ
    J Immunol; 1984 Jul; 133(1):515-8. PubMed ID: 6373933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo modulation of macrophage tumoricidal activity by oral administration of the liposome-encapsulated macrophage activator CGP 19835A.
    Tanguay S; Bucana CD; Wilson MR; Fidler IJ; von Eschenbach AC; Killion JJ
    Cancer Res; 1994 Nov; 54(22):5882-8. PubMed ID: 7954418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide.
    Schroit AJ; Fidler IJ
    Cancer Res; 1982 Jan; 42(1):161-7. PubMed ID: 7053846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of interferon-alpha A/D in combination with the Japanese and Chinese traditional herbal medicine juzen-taiho-to on lung metastasis of murine renal cell carcinoma.
    Muraishi Y; Mitani N; Yamaura T; Fuse H; Saiki I
    Anticancer Res; 2000; 20(5A):2931-7. PubMed ID: 11062703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of liposomes containing synthetic bacterial cell wall analogues for tumoricidal activation of monocytes and macrophages.
    Utsugi T; Nii A; Fan D; Pak CC; Denkins Y; van Hoogevest P; Fidler IJ
    Cancer Immunol Immunother; 1991; 33(5):285-92. PubMed ID: 1868486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of tumoricidal macrophages from lung melanoma metastases of mice treated systemically with liposomes containing a lipophilic derivative of muramyl dipeptide.
    Key ME; Talmadge JE; Fogler WE; Bucana C; Fidler IJ
    J Natl Cancer Inst; 1982 Nov; 69(5):1198-98. PubMed ID: 6957661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism of local tumor irradiation combined with interleukin 2 therapy in murine renal carcinoma: histological evaluation of pulmonary metastases.
    Dezso B; Haas GP; Hamzavi F; Kim S; Montecillo EJ; Benson PD; Pontes JE; Maughan RL; Hillman GG
    Clin Cancer Res; 1996 Sep; 2(9):1543-52. PubMed ID: 9816331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of nitric oxide production and tumoricidal properties in murine macrophages by a new synthetic lipopeptide JBT3002 encapsulated in liposomes.
    Eue I; Kumar R; Dong Z; Killion JJ; Fidler IJ
    J Immunother; 1998 Sep; 21(5):340-51. PubMed ID: 9789196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy of interleukin-2 and sorafenib improves survival benefits and prevents spontaneous pulmonary metastasis in murine renal cell carcinoma models.
    Amagai Y; Matsumoto M; Hojo K; Iguchi M; Wada T; Tanaka H; Ide N; Kato A; Shichijo M; Abe K
    Jpn J Clin Oncol; 2010 Jun; 40(6):503-7. PubMed ID: 20106881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of alveolar macrophage tumoricidal activity and eradication of experimental metastases by freeze-dried liposomes containing a new lipophilic muramyl dipeptide derivative.
    Phillips NC; Moras ML; Chedid L; Lefrancier P; Bernard JM
    Cancer Res; 1985 Jan; 45(1):128-34. PubMed ID: 3838084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of liposome-encapsulated indomethacin in response against metastatic 3LL and B16F1 tumor cells.
    Aliño SF; Unda FJ; Iruarrizaga A; Alfaro J; Hilario E; Pérez-Yarza G; Bobadilla M; Lejarreta M
    Lab Invest; 1992 Jun; 66(6):671-9. PubMed ID: 1602737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of murine macrophage tumoricidal activity and treatment of experimental pulmonary metastases by liposomes containing lipophilic muramyl dipeptide analogs.
    Phillips NC; Chedid L; Bernard JM; Level M; Lefrancier P
    J Biol Response Mod; 1987 Dec; 6(6):678-91. PubMed ID: 3450784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.